Late Breaking Abstract - Study of natural autoantibodies in rheumatoid arthritis patients with pulmonary involvement

C. Triantafyllidis (Kavala, Greece)

Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Session: Late-breaking studies in pulmonary diseases
Session type: Oral Presentation
Number: 2894

Congress or journal article abstractE-posterSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Triantafyllidis (Kavala, Greece). Late Breaking Abstract - Study of natural autoantibodies in rheumatoid arthritis patients with pulmonary involvement. 2894

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary involvement in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 381s
Year: 2006

Pulmonary manifestations in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006

Pulmonary involvement in rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Pulmonary involvement in rheumatoid arthritis
Source: Eur Respir Monogr 2019; 86: 44-67
Year: 2019


Lung involvement in patients with rheumatoid artritis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017


Pulmonary involvement in spondilarthropathies and rheumatoid polyarthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

Pulmonary disease associated with rheumatoid arthritis
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021

Pulmonary nodular lesions in rheumatoid arthritis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Interstitial lung disease in patients with rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Drug-induced lung disease in rheumatoid arthritis: critical review of patterns
Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective
Year: 2009

Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Pulmonary abnormalities in newly diagnosed rheumatoid arthritis
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Involving lung in rheumatoid arthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Prognosis in rheumatoid arthritis patients with COPD: A nationwide, registry-based study
Source: International Congress 2017 – COPD: risk factors and prognosis
Year: 2017



Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018
Year: 2019



Rituximab improves interstitial lung disease in rheumatoid arthritis patients
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Analysis of lung diseases associated with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 307s
Year: 2006

Interstitial lung disease in new onset rheumatoid arthritis: a 5 year prospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006